Lynbrook / New York / United States
BioSpecifics Technologies is a biopharmaceutical company with a focus on wound healing and tissue remodeling. The company has developed the application of Collagenase for several disease conditions, notably dermal ulcers, pressure sores and second and third degree burns. The company produces Collagenase ABC, the essential ingredient in the prescription drug Collagenase Santyl Ointment. The company has also partnered with Auxilium Pharmaceuticals to develop and commercialize Collagenase for injection for the treatment of Dupuytrens disease, Peyronies disease and Frozen Shoulder. BioSpecifics Technologies is a publicly traded company. Its shares are listed on the NASDAQ under the ticker symbol AUXL. The company is headquartered in Lynbook, N.Y.
